… used for novel foods The European Union has released its strategy … first part of the upcoming EU Biotech Act, which is expected to … lengthy authorisation process via the European Food Safety Authority (EFSA), which …

… position Europe as a global leader in advanced therapeutics.  Fusix Biotech: Fighting … of BIO-Europe 2025 was the announcement of Fusix Biotech GmbH as … BIO-Europe was VAR2 Pharmaceuticals ApS, a Danish clinical-stage biotech spun …

… equity investments across Continental Europe – the biggest being ASML … said that valuations of European companies still remain attractive … positive investor sentiment towards European equity markets," … (12.1%), pharma, biotech and life sciences (11.4% …

… being used across the EU as proof that innovation … said. He added that EU institutions had recognised the EIT … said. He also highlighted biotech ventures using digital models of … Angelova Krasteva from the European Commission delivered opening remarks framing …

… biomass processing, biomanufacturing, and biotechnologies. In all these sectors, … untapped potential,” says the European Commission.  “This is … , and jobs in Europe,” Roswall insisted at the … Bio-based Europe Alliance to bring together EU companies …

… , aquaculture, biomass processing, biomanufacturing and biotechnologies. Examples of products include bio … a Bio-based Europe Alliance which will gather EU companies to collectively … Statement to officials at the European Commission’s Directorate-General for …

… NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global … in Flanders as one of Europe’s largest CAR-T … Buysse, General Manager, Legend Biotech Belgium. “Through our partnerships … & Johnson. In the EU, cilta-cel is approved under …

… therapeutics and vaccines reshape biotech manufacturing across Europe and globally. ROCKVILLE PIKE … sustained vaccine demand. Regional snapshot — Europe: Europe is expected to remain a …

… MSD International Business GmbH, after European approval of a subcutaneous (SC … ) formulation that uses the Korean biotech’s human hyaluronidase technology. In … payment is tied to the European marketing authorization of Keytruda SC …

In terms of type, monoclonal antibody segment to command 64.0% share in the antibody production market in 2025. ROCKVILLE, MD, UNITED STATES, November 27, 2025 /⁨EINPresswire.com⁩/ -- The global antibody production market is positioned for …